Active Substance: Boceprevir.
Overview
Welcome to Dwaey, specifically on VICTRELIS 200mg page.
This medicine contains an important and useful components, as it consists of
Bocepreviris available in the market in concentration
Diphtheria toxoids + tetanus toxoids + pertussis toxoid + inactivated Poliomyelitis virus + Haemophilus influenzae type b Vaccine
Before receiving the **Diphtheria Toxoids + Tetanus Toxoids + Pertussis Toxoid + Inactivated Poliomyelitis Virus + Haemophilus Influenzae Type B Vaccine**, individuals should consult with their healthcare provider to assess any potential risks. Precautions to consider include: - **Allergic Reactions**: Patients with a history of **allergies** to any components of the vaccine (such as **formaldehyde**, **neomycin**, **polysorbate 80**, or **yeast**) should avoid this vaccine. In rare cases, **anaphylaxis** or severe allergic reactions may occur. Symptoms include **hives**, **difficulty breathing**, and **swelling of the face or throat**. - **Neurological History**: Individuals with a history of **neurological disorders** such as **seizures** or **Guillain-Barré syndrome** following a previous dose of the DTaP or DTP vaccine should discuss their medical history with their healthcare provider before receiving the vaccine. - **Immunocompromised Individuals**: Those with weakened immune systems (e.g., due to **HIV/AIDS**, **chemotherapy**, or **organ transplantation**) may not respond as effectively to the vaccine, and should receive medical advice before vaccination. - **Pregnancy and Breastfeeding**: Generally, the vaccine is safe for pregnant and breastfeeding individuals, but it should be administered only if necessary and after consulting with a healthcare provider, especially during pregnancy. - **Moderate to Severe Illness**: This vaccine should not be given if the patient is experiencing a **moderate to severe illness**, particularly one with a **fever**. For minor illnesses, such as a cold, vaccination can proceed with healthcare provider approval.
This combination vaccine provides protection against several serious infectious diseases: 1. **Diphtheria**: A potentially fatal bacterial infection caused by *Corynebacterium diphtheriae*, which affects the respiratory system and can lead to breathing difficulties, heart failure, or death if untreated. 2. **Tetanus**: Caused by the *Clostridium tetani* bacterium, this disease leads to muscle stiffness and spasms and can cause life-threatening complications like respiratory failure. 3. **Pertussis (Whooping Cough)**: A highly contagious respiratory disease caused by *Bordetella pertussis*, leading to severe coughing spells and potential complications, especially in infants and young children. 4. **Poliomyelitis**: A viral infection caused by the **poliovirus**, leading to paralysis and even death. The vaccine prevents polio by stimulating immunity to the inactivated virus. 5. **Haemophilus Influenzae Type B (HIB)**: This bacterial infection can cause **meningitis**, **pneumonia**, and other serious diseases, particularly in children under five. The vaccine prevents infection caused by *Haemophilus influenzae* type b. This vaccine is commonly administered as part of **routine childhood immunization** schedules, offering protection from these life-threatening diseases.
The **Diphtheria Toxoids + Tetanus Toxoids + Pertussis Toxoid + Inactivated Poliomyelitis Virus + Haemophilus Influenzae Type B Vaccine** should be avoided in the following situations: - **Severe Allergic Reaction**: If an individual has previously experienced a severe allergic reaction to any component of the vaccine (including **formaldehyde**, **neomycin**, **polysorbate 80**, or **yeast**), they should not receive this vaccine. - **Severe Neurological Event**: The vaccine should be avoided in individuals who have had a **severe neurological event** (such as **encephalopathy** or **seizures**) after a previous **DTP** or **DTaP** vaccine. - **Severe Illness or Fever**: If the patient is suffering from a **moderate or severe illness**, particularly one with **fever**, the vaccine should be postponed until recovery. Mild illnesses such as a cold are generally not a reason to delay vaccination. - **History of Guillain-Barré Syndrome**: People with a history of **Guillain-Barré syndrome** following previous doses of **tetanus vaccines** or other vaccines containing **diphtheria toxoid** should avoid receiving this combination vaccine.
The vaccine can cause mild to moderate side effects, with the following common reactions: - **Injection Site Reactions**: **Redness**, **swelling**, or **pain** at the site of injection are common and usually resolve within a few days. - **Fever**: A low-grade **fever** may occur after vaccination, typically subsiding within 1-2 days. - **Irritability and Fatigue**: Some children may become **irritable** or excessively **tired** following the vaccine. - **Loss of Appetite**: Reduced appetite is another common reaction, particularly in infants and children. - **Mild Rash**: A mild **skin rash** may occur but is generally not a cause for concern. Serious side effects are rare but may include: - **Severe Allergic Reactions**: Symptoms include **difficulty breathing**, **swelling of the throat**, **hives**, and a potential **anaphylactic reaction**. - **Seizures**: **Febrile seizures** may occur in some children, particularly if a high fever develops after the vaccine. - **Severe Nervous System Reactions**: Although rare, **neurological reactions**, such as **Guillain-Barré syndrome**, can occur in individuals who have a history of this condition after a previous vaccine. - **Persistent Crying in Infants**: Some infants may cry for **more than 3 hours** following vaccination, which can be distressing but usually resolves with time.
3
The **Diphtheria Toxoids + Tetanus Toxoids + Pertussis Toxoid + Inactivated Poliomyelitis Virus + Haemophilus Influenzae Type B Vaccine** works by stimulating the body’s immune system to produce protective antibodies against the bacteria or viruses that cause these diseases: - **Diphtheria and Tetanus Toxoids**: The vaccine contains **inactivated forms of the toxins** produced by the **Corynebacterium diphtheriae** and **Clostridium tetani** bacteria. These toxoids stimulate the immune system to create **antibodies** that prevent the harmful effects of these toxins. - **Pertussis Toxoid**: This component of the vaccine includes inactivated **pertussis toxin** and other antigens from *Bordetella pertussis*. The body generates **antibodies** that neutralize the bacteria, preventing **whooping cough**. - **Inactivated Polio Virus**: The vaccine contains **inactivated poliovirus** strains, which stimulate the immune system to produce **antibodies** against the virus. This prevents **polio** by making the immune system recognize and fight off the virus. - **Haemophilus Influenzae Type B**: This part of the vaccine includes a **polysaccharide antigen** from *Haemophilus influenzae* type b. It induces the body’s immune system to develop **antibodies** to fight off infections caused by this bacterium, especially **meningitis** and **pneumonia**.
The **Diphtheria Toxoids + Tetanus Toxoids + Pertussis Toxoid + Inactivated Poliomyelitis Virus + Haemophilus Influenzae Type B Vaccine** may interact with other medications or vaccines: - **Immunosuppressive Medications**: Drugs that suppress the immune system, such as **corticosteroids**, **chemotherapy**, or **immunosuppressants**, may reduce the effectiveness of the vaccine. It is essential to consult with a healthcare provider before receiving this vaccine if you are taking immunosuppressive medications. - **Blood Products**: People who have recently received **blood transfusions** or **immunoglobulin** therapy may experience a **diminished immune response** to the vaccine. It may be advised to delay vaccination if these treatments have been received. - **Other Vaccines**: This vaccine can be co-administered with other vaccines, such as the **MMR (measles, mumps, rubella)** vaccine or **varicella** vaccine, without significant interactions. However, the scheduling of these vaccines should be done by a healthcare provider.
Information not available
The **Diphtheria Toxoids + Tetanus Toxoids + Pertussis Toxoid + Inactivated Poliomyelitis Virus + Haemophilus Influenzae Type B Vaccine** is primarily intended for **children** as part of the routine vaccination schedule. However, adults may also receive booster doses of individual components of the vaccine, particularly for **tetanus** and **diphtheria**. These doses may be recommended in the following situations: - For adults who have missed their childhood vaccinations or need a **tetanus-diphtheria (Td)** booster. - For **travelers** to regions where **polio** or **pertussis** is still prevalent. - **Healthcare workers** who are at higher risk of exposure to these diseases.
The **Diphtheria Toxoids + Tetanus Toxoids + Pertussis Toxoid + Inactivated Poliomyelitis Virus + Haemophilus Influenzae Type B Vaccine** is typically administered to infants and children according to the following schedule: - **First Dose**: Administered at **2 months** of age. - **Second Dose**: Given at **4 months** of age. - **Third Dose**: Administered at **6 months** of age. - **Fourth Dose (Booster)**: Given at **15-18 months** of age. - **Fifth Dose (Final Booster)**: Administered between **4-6 years** of age. This schedule may vary slightly based on the specific vaccine brand or country’s immunization schedule. Parents and caregivers should consult a healthcare provider to ensure the correct vaccination timeline for their child.
No specific **renal dose adjustments** are required for individuals with **renal impairment**. However, it is important to note that **immunocompromised** individuals, including those with **chronic kidney disease** receiving immunosuppressive treatments, may not develop the same immune response to the vaccine. Consultation with a healthcare provider is crucial before vaccination.
Information not available